ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TEMPORARY UNAVAILABILITY OF NATESTO® IN CANADA AND SOUTH KOREA
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 215336" data-attributes="member: 13851"><div style="text-align: justify; max-width: %s">[URL unfurl="true"]https://www.aceruspharma.com/English/news/press-release-details/2022/Acerus-Pharmaceuticals-Announces-Commercial-Agreement-With-Verity-Pharmaceuticals-for-the-Promotion-of-NATESTO-in-Puerto-Rico/default.aspx[/URL]</div> </p><p></p><div style="text-align: justify; max-width: %s"><strong>ACERUS PHARMACEUTICALS ANNOUNCES COMMERCIAL AGREEMENT WITH VERITY PHARMACEUTICALS FOR THE PROMOTION OF NATESTO® IN PUERTO RICO</strong></div> </p><p><strong>01/10/2022</strong></p><p></p><div style="text-align: justify; max-width: %s"><em><strong>Verity Pharmaceuticals will begin promoting NATESTO to health care professionals throughout Puerto Rico in Q1, 2022. </strong>This agreement represents a new partnership and the continued expansion of NATESTO into new markets.</em></div> </p><p></p><div style="text-align: justify; max-width: %s"><em><strong>TORONTO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced the signing of an agreement with Verity Pharmaceuticals (“Verity Pharma”) for the exclusive rights to promote NATESTO in Puerto Rico.</strong> Verity Pharma is a privately-owned pharmaceutical company with offices in Canada, the United States, and Ireland that specializes in providing innovative, market-leading pharmaceutical products to patients across North America. <strong>Under the terms of the agreement, Verity Pharma will promote NATESTO across the island of Puerto Rico, leveraging its existing commercial footprint and health care network. Acerus will maintain control of distribution, market access, and regulatory activities on the island of Puerto Rico.</strong></em></div> </p><div style="text-align: justify; max-width: %s"><em>“Acerus is very pleased to be partnering with Verity Pharma to continue to increase the market penetration of NATESTO,” said Edward Gudaitis, President and Chief Executive Officer of Acerus. "Verity Pharma’s established and significant salesforce and healthcare network in Puerto Rico will be the catalyst to expand patient access to NATESTO.”</em></div> </p><div style="text-align: justify; max-width: %s"><em>“Verity Pharma is extremely pleased with the addition of NATESTO to the Puerto Rico Health Care system. NATESTO has significant value to patients suffering from hypogonadism,” said Howard Glase, CEO of Verity Pharma. “Moreover, Verity Pharma is proud to work with Acerus and facilitate the commercialization of NATESTO in Puerto Rico."</em></div></blockquote><p></p>
[QUOTE="madman, post: 215336, member: 13851"] [JUSTIFY='%s'][URL unfurl="true"]https://www.aceruspharma.com/English/news/press-release-details/2022/Acerus-Pharmaceuticals-Announces-Commercial-Agreement-With-Verity-Pharmaceuticals-for-the-Promotion-of-NATESTO-in-Puerto-Rico/default.aspx[/URL][/JUSTIFY] [JUSTIFY='%s'][B]ACERUS PHARMACEUTICALS ANNOUNCES COMMERCIAL AGREEMENT WITH VERITY PHARMACEUTICALS FOR THE PROMOTION OF NATESTO® IN PUERTO RICO[/B][/JUSTIFY] [B]01/10/2022[/B] [JUSTIFY='%s'][I][B]Verity Pharmaceuticals will begin promoting NATESTO to health care professionals throughout Puerto Rico in Q1, 2022. [/B]This agreement represents a new partnership and the continued expansion of NATESTO into new markets.[/I][/JUSTIFY] [JUSTIFY='%s'][I][B]TORONTO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced the signing of an agreement with Verity Pharmaceuticals (“Verity Pharma”) for the exclusive rights to promote NATESTO in Puerto Rico.[/B] Verity Pharma is a privately-owned pharmaceutical company with offices in Canada, the United States, and Ireland that specializes in providing innovative, market-leading pharmaceutical products to patients across North America. [B]Under the terms of the agreement, Verity Pharma will promote NATESTO across the island of Puerto Rico, leveraging its existing commercial footprint and health care network. Acerus will maintain control of distribution, market access, and regulatory activities on the island of Puerto Rico.[/B][/I][/JUSTIFY] [JUSTIFY='%s'][I]“Acerus is very pleased to be partnering with Verity Pharma to continue to increase the market penetration of NATESTO,” said Edward Gudaitis, President and Chief Executive Officer of Acerus. "Verity Pharma’s established and significant salesforce and healthcare network in Puerto Rico will be the catalyst to expand patient access to NATESTO.”[/I][/JUSTIFY] [JUSTIFY='%s'][I]“Verity Pharma is extremely pleased with the addition of NATESTO to the Puerto Rico Health Care system. NATESTO has significant value to patients suffering from hypogonadism,” said Howard Glase, CEO of Verity Pharma. “Moreover, Verity Pharma is proud to work with Acerus and facilitate the commercialization of NATESTO in Puerto Rico."[/I][/JUSTIFY] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TEMPORARY UNAVAILABILITY OF NATESTO® IN CANADA AND SOUTH KOREA
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top